HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The partial agonist properties of levocabastine in neurotensin-induced analgesia.

Abstract
The antihistaminic drug levocabastine is a ligand for the low affinity neurotensin receptor (NTS2). Its intracerebroventricular administration to mice induced a significant analgesia in the writhing test but not in the hot plate test. In the writhing test, levocabastine decreased neurotensin-induced analgesia to a level not significantly different from the effects of levocabastine alone. In the hot plate test, levocabastine had no analgesic effect but completely reversed the neurotensin-induced analgesia. Mepyramine, another antihistaminic drug, did not share these levocabastine effects. Neither levocabastine nor mepyramine modified the colonic temperature or reversed the neurotensin-induced hypothermia. Thus, levocabastine behaves as a partial agonist at neurotensin NTS2 receptors, which are involved in visceral nociception, but not at yet unidentified neurotensin receptors involved in hypothermia.
AuthorsI Dubuc, S Remande, J Costentin
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 381 Issue 1 Pg. 9-12 (Sep 17 1999) ISSN: 0014-2999 [Print] Netherlands
PMID10528128 (Publication Type: Journal Article)
Chemical References
  • Analgesics
  • Histamine H1 Antagonists
  • Piperidines
  • Receptors, Neurotensin
  • Neurotensin
  • levocabastine
  • Pyrilamine
Topics
  • Analgesia
  • Analgesics (pharmacology)
  • Animals
  • Dose-Response Relationship, Drug
  • Histamine H1 Antagonists (pharmacology)
  • Male
  • Mice
  • Neurotensin (pharmacology)
  • Pain (chemically induced, prevention & control)
  • Pain Threshold (drug effects)
  • Piperidines (pharmacology)
  • Pyrilamine (pharmacology)
  • Receptors, Neurotensin (agonists)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: